Background illustration for clinical trials search

Esophageal Cancer Clinical Trials

Browse 222 esophageal cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

for
Advanced Esophageal Squamous Cell Carcinoma,
Location: Jacksonville FL
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06265285

Phase2, Recruiting

Prehab for Lung and Esophageal Cancer

for
Neoplasm of Lung, Neoplasms, Exercise, Surgery
Location: Halifax
Sponsor: Nova Scotia Health Authority

Sex: All

Age: 18+

Code: NCT06354959

Recruiting

NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer

for
Cervical Esophagus Adenocarcinoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04615013

Phase1, Recruiting

Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy

for
Gastric Cancers
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 0+

Code: NCT01416714

Recruiting

Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests

for
Gastro Esophageal Reflux Disease, Barrett Esophagus
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 18 - 70+

Code: NCT06693622

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Folfox+Irinotecan+Chemort In Esophageal Cancer

for
Gastroesophageal Junction Adenocarcinoma,
Location: Boston MA, Newton MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT04656041

Phase2, Recruiting

Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer

for
Esophagus Adenocarcinoma, Esophagus Squamous Cell Carcinoma,
Location: Dallas TX
Sponsor: Dallas VA Medical Center

Sex: All

Age: 18+

Code: NCT04018872

Phase2, Recruiting

Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients

for
Gastric Cancer, Gastrointestinal Cancer, HER2 Gene Mutation
Location: Philadelphia PA, Buffalo NY, Palo Alto CA
Sponsor: Fox Chase Cancer Center

Sex: All

Age: 18+

Code: NCT05274048

Phase1, Recruiting

Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus

for
Barrett Esophagus,
Location: Chapel Hill NC, Ann Arbor MI, St Louis MO, Dallas TX
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06732388

Phase2, Recruiting

Effectiveness and Performance of an Optical Biopsy Technology for Esophageal Cancer in Brazil and the United States

for
Suspected or Known Squamous Cell Neoplasia,
Location: Houston TX
Sponsor: Baylor College of Medicine

Sex: All

Age: 18+

Code: NCT06435286

Phase2, Recruiting

Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors

for
Gastric Cancer, Gastro-esophageal Junction Cancer,
Location: Jacksonville FL, Rochester MN
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06005493

Phase1, Phase2, Recruiting

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

for
Cervical Cancer,
Location: Hackensack NJ, Montreal, Hamilton, Nashville TN,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT04895709

Phase1, Phase2, Recruiting

A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors

for
Squamous Non-small-cell Lung Cancer,
Location: New Haven CT, Hackensack NJ, Fairfax VA, Louisville KY,
Sponsor: Alentis Therapeutics AG

Sex: All

Age: 18+

Code: NCT06747585

Phase1, Phase2, Recruiting

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

for
HER2-positive Gastric Cancer,
Location: Chicoutimi, New York NY, Summit NJ, Montreal,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06764875

Phase3, Recruiting

Lucid Registry Study

for
Barrett Esophagus, Esophageal Adenocarcinoma,
Location: Lake Forest CA
Sponsor: Lucid Diagnostics, Inc.

Sex: All

Age: 12+

Code: NCT05965999

Recruiting

Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer

for
Esophageal Squamous Cell Carcinoma
Location: Montreal
Sponsor: Karolinska University Hospital

Sex: All

Age: 18 - 70+

Code: NCT04460352

Phase3, Recruiting

Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance

for
Barrett Esophagus, Barretts Esophagus With Dysplasia,
Location: Bristol CT, New Hyde Park NY, New York NY, Danville PA,
Sponsor: University of Colorado, Denver

Sex: All

Age: 18 - 70+

Code: NCT05530343

Recruiting

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

for
Early Stage Triple-Negative Breast Carcinoma,
Location: Jacksonville FL, Rochester MN, Phoenix AZ
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06349642

Recruiting

A Study of KK2269 in Adult Participants With Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor,
Location: Jacksonville FL, St Louis MO, Dallas TX, Scottsdale AZ,
Sponsor: Kyowa Kirin Co., Ltd.

Sex: All

Age: 18+

Code: NCT06266299

Phase1, Recruiting

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

for
Solid Tumor, Advanced Cancer, Metastatic Cancer, Gastric Cancer,
Location: Boston MA, New York NY, Madison WI, Aurora CO,
Sponsor: I-Mab Biopharma US Limited

Sex: All

Age: 18+

Code: NCT04900818

Phase1, Recruiting